Pharming Group N.V. ( PHAR) - Key Metrics
PHAR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.14 | $0.01 | $0.01 | $0.01 |
| 2025Q3 | $0.15 | $0.01 | $0.05 | $0.05 |
| 2025Q2 | $0.14 | $0.01 | $0.02 | $0.02 |
| 2025Q1 | $0.12 | -$0.02 | $0 | $0 |
PHAR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 51.81 |
| 2025Q3 | ? | 27.48 |
| 2025Q2 | ? | 32.44 |
| 2025Q1 | ? | -8.83 |
PHAR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.12% | ? |
| 2025Q4 | 0.61% | ? |
| 2025Q3 | 3.09% | ? |
| 2025Q2 | 1.62% | ? |
| 2025Q1 | -0.01% | ? |
PHAR
Price: $12.52
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 68.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1500
Market Capitalization: 923.9 million